skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: The theoretical basis and clinical methodology for stereotactic interstitial brain tumor irradiation using iododeoxyuridine as a radiation sensitizer and samarium-145 as a brachytherapy source

Conference ·
OSTI ID:7192249
; ; ;  [1]; ;  [2]
  1. Ohio State Univ., Columbus, OH (USA)
  2. Brookhaven National Lab., Upton, NY (USA)

High grade astrocytomas have proven resistant to all conventional therapy. A technique to produce radiation enhancement during interstitial brain tumor irradiation by using a radiation sensitizer (IdUrd) and by stimulation of Auger electron cascades through absorption of low energy photons in iodine (Photon activation) is described. Clinical studies using IdUrd, {sup 192}Ir as a brachytherapy source, and external radiation have produced promising results. Substituting samarium-145 for {sup 192}Ir in this protocol is expected to produce enhanced results. 15 refs.

Research Organization:
Brookhaven National Lab., Upton, NY (USA)
Sponsoring Organization:
DOE/ER
DOE Contract Number:
AC02-76CH00016
OSTI ID:
7192249
Report Number(s):
BNL-44560; CONF-8910409-1; ON: DE90011518; TRN: 90-026996
Resource Relation:
Conference: 10. meeting of the world society for stereotactic and functional neurosurgery, Maebashi (Japan), 2-5 Oct 1989
Country of Publication:
United States
Language:
English

Similar Records

Treatment results of stereotactic interstitial brachytherapy for primary and metastatic brain tumors
Journal Article · Thu Aug 01 00:00:00 EDT 1991 · International Journal of Radiation Oncology, Biology and Physics; (United States) · OSTI ID:7192249

Samarium-145 and its use as a radiation source
Patent · Sun Jan 01 00:00:00 EST 1989 · OSTI ID:7192249

Samarium-145 and its use as a radiation source
Patent · Tue Sep 05 00:00:00 EDT 1989 · OSTI ID:7192249